Choice of first line treatment and survival in metastatic colorectal cancer: a retrospective analysis

Oliveira, A.; Bretes, L.; Furtado, I.

http://hdl.handle.net/10400.1/9450

Utilize este identificador para referenciar este registo.

Nome:	Descrição:	Tamanho:	Formato:
9450 Choice of first line treatment.pdf		36.62 KB	Adobe PDF	Ver/Abrir

Contacte-nos

Autores

Oliveira, A.

Bretes, L.

Furtado, I.

Resumo(s)

Introduction: Selection of first line treatment for patients with metastatic colorectal cancer (mCRC) is based on tumour and patient related factors. The wide and increasingly use of targeting agents in this setting are proven to be beneficial in first line treatment. Increasing evidence suggests that this first line treatment is of great importance and its impact is being studied in prospective studies. In this retrospective analysis, we aimed to analyze the first treatment used and its potential impact on overall survival (OS).

URI

http://hdl.handle.net/10400.1/9450

Editora

Oxford University Press

DOI

https://doi.org/10.1093/annonc/mdw199.157

Coleções

FCB2-Artigos (em revistas ou actas indexadas)

Métricas Alternativas

Ver registo completo